MARKET

VYGR

VYGR

Voyager Therapeutics Inc
NASDAQ
4.230
-0.150
-3.42%
After Hours: 4.240 +0.01 +0.24% 19:33 02/14 EST
OPEN
4.380
PREV CLOSE
4.380
HIGH
4.600
LOW
4.200
VOLUME
442.05K
TURNOVER
--
52 WEEK HIGH
10.66
52 WEEK LOW
4.001
MARKET CAP
231.07M
P/E (TTM)
7.20
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VYGR last week (0210-0214)?
Weekly Report · 18h ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Q32 Bio (QTTB) and Vaxcyte (PCVX)
TipRanks · 4d ago
Voyager Therapeutics Executives Cash In: A Look at Recent Stock Sales
TipRanks · 5d ago
Voyager Therapeutics price target lowered to $12 from $14 at Wells Fargo
TipRanks · 5d ago
VOYAGER THERAPEUTICS, INC. <VYGR.O>: WELLS FARGO CUTS TARGET PRICE TO $12 FROM $14
Reuters · 5d ago
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Staar Surgical (STAA) and Hyperfine (HYPR)
TipRanks · 5d ago
Insiders Sold Voyager Therapeutics Prematurely At US$7.47 With Stock Trading Higher
Simply Wall St · 5d ago
More
About VYGR
Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs, all of which are in preclinical development, include Anti-Tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy Program, Tau Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program, and others. VY-TAU01 is for the treatment of Alzheimer’s disease. SOD1 Silencing Gene Therapy Program is for the treatment of ALS.

Webull offers Voyager Therapeutics Inc stock information, including NASDAQ: VYGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYGR stock methods without spending real money on the virtual paper trading platform.